PUNICALAGIN AND PUNICALIN SUPPRESS THE ADIPOCYTE DIFFERENTIATION THROUGH THE TRANSCRIPTION FACTORS.

Acta Endocrinol (Buchar)

Mersin University, Faculty of Medicine - Department of Biophysics, Mersin, Turkey.

Published: January 2021

Background: Pomegranate is a rich source of many polyphenolic compounds including ellagitannins (punicalagin, punicalin and others).

Aim: The effects of punicalagin and punicalin on adipogenesis were investigated in this study.

Materials And Methods: To examine the effect of punicalagin and punicalin on adipocyte differentiation, various concentrations of punicalagin and punicalin (2-10 µM) were applied to differentiated 3T3-L1 cells. Glyceraldehyde-3-phosphate dehydrogenase (GPDH) activity, Oil red O staining, intracellular triglyceride levels, and gene expressions of transcription factors (Peroxisome proliferator-activated receptor-γ (PPARγ), CCAAT-enhancer-binding proteins-α (C/EBPα), Sterol regulatory element-binding protein 1c (SREBP-1c)) and lipolysis-associated genes (hormone-sensitive lipase (HSL), Perilipin A, tumor necrosis factor-α (TNF-α)) were examined in order to investigate the effects of punicalagin and punicalin on adipocyte differentiation.

Results: Punicalagin and punicalin applications caused a continuous decrease in cell size and intracellular triglyceride accumulation. GPDH activity and transcription gene expressions decreased significantly in groups that were applicated punicalagin and punicalin at high concentrations. Punicalagin, but not punicalin, down-regulated the expression of HSL and perilipin A and up-regulated the expression of TNF-α in a dose-dependent manner. In conclusion, both punicalagin and punicalin were able to inhibit the adipocyte differentiation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665253PMC
http://dx.doi.org/10.4183/aeb.2021.157DOI Listing

Publication Analysis

Top Keywords

punicalagin punicalin
40
adipocyte differentiation
12
punicalagin
10
punicalin
9
transcription factors
8
effects punicalagin
8
punicalin adipocyte
8
concentrations punicalagin
8
gpdh activity
8
intracellular triglyceride
8

Similar Publications

Analysis of Punicalin and Punicalagin Interaction with PDIA3 and PDIA1.

Int J Mol Sci

September 2024

Department of Biochemical Science "A. Rossi Fanelli", Faculty of Farmacy and Medicine, Sapienza University of Rome, Pl. A. Moro 5, 00185 Rome, Italy.

Article Synopsis
  • PDIA3 is an important protein in the endoplasmic reticulum that plays a key role in protein folding and is linked to diseases like cancer and neurodegeneration.
  • Punicalagin is a promising but non-selective PDIA3 inhibitor, prompting the exploration of its derivative, punicalin, which has a simpler structure and better selectivity towards PDIA3.
  • Studies show that punicalin effectively binds and inhibits PDIA3, demonstrating higher selectivity compared to PDIA1, and causes significant changes in PDIA3's thermal stability, highlighting its potential for developing selective PDIA3 inhibitors.
View Article and Find Full Text PDF

Despite remarkable breakthroughs in pharmacotherapy, many potential therapies for aging remain unexplored. Punicalin (PUN), an ellagitannin component, exerts anti-inflammatory, antioxidant, and anti-apoptotic effects. This study investigated the beneficial effects of PUN against age-related brain damage in mice and explored the underlying mechanisms.

View Article and Find Full Text PDF

Introduction: Diabetic retinopathy is the major cause of vision failure in diabetic patients, and the current treatment involves the practice of glucocorticoids or VEGF antagonists that are "off-label". A few small organic molecules against DR were discovered many years ago. Nutraceuticals are naturally available functional foods that endorse different health benefits, including vitamins, antioxidants, minerals, fatty acids, and amino acids that can defer the development of some diseases.

View Article and Find Full Text PDF
Article Synopsis
  • Nucleoside analogs are the main antiviral drugs used for treating feline herpesvirus-1 (FHV-1), but they face issues like drug resistance and a limited mechanism of action.
  • This research highlights the need for new antiviral drugs and investigates natural compounds that can effectively target the virus's glycoprotein B (gB) using techniques like Bio-layer interferometry (BLI).
  • The study found that compounds Saikosaponin B2, Punicalin, and Punicalagin demonstrated strong antiviral effects against FHV-1 without being toxic to cells, particularly by preventing the virus from entering cells in the early stages of infection.
View Article and Find Full Text PDF

Inhibition of NS2B-NS3 protease from all four serotypes of dengue virus by punicalagin, punicalin and ellagic acid identified from .

J Biomol Struct Dyn

February 2024

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering College, Pakistan Institute of Engineering and Applied Sciences (NIBGE-C, PIEAS), Faisalabad, Punjab, Pakistan.

Despite a major threat to the public health in tropical and subtropical regions, dengue virus (DENV) infections are untreatable. Therefore, efforts are needed to investigate cost-effective therapeutic agents that could cure DENV infections in future. The NS2B-NS3 protease encoded by the genome of DENV is considered a critical target for the development of anti-dengue drugs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!